If They Get a Lot of Attention, Does It Really Matter Whether They're Right? | GenomeWeb

The Economist has a story following a PLoS Medicine paper from John Ioannidis and colleagues which argues that scientific publishing may be biased toward high-profile papers that may have less accurate findings. "With so many scientific papers chasing so few pages in the most prestigious journals, the winners could be the ones most likely to oversell themselves," the article says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.